Healthcare stocks in United Kingdom

Intrinsic value and value investing analysis for healthcare stocks in United Kingdom.

19 companies

Companies

• AZN - Astrazeneca plc: slightly overvalued, -14% margin of safety
• GSK - GSK Plc ADR: undervalued, +33% margin of safety
• HLN - Haleon plc ADR: slightly overvalued, -16% margin of safety
• ROIV - Roivant Sciences Ltd: overvalued, -461% margin of safety
• SNN - Smith & Nephew plc ADR: overvalued, -24% margin of safety
• KNSA - Kiniksa Pharmaceuticals International Plc: overvalued, -136% margin of safety
• LIVN - LivaNova PLC: overvalued, -38% margin of safety
• CMPS - Compass Pathways Plc ADR: no published value
• IMCR - Immunocore Holdings plc ADR: undervalued, +30% margin of safety
• NVCR - NovoCure Ltd: overvalued, -88% margin of safety
• SLN - Silence Therapeutics Plc ADR: overvalued, -1573% margin of safety
• AUTL - Autolus Therapeutics plc ADR: overvalued, -255% margin of safety
• BCYC - Bicycle Therapeutics Plc ADR: undervalued, +71% margin of safety
• OKYO - OKYO Pharma Limited: no published value
• MREO - Mereo Biopharma Group Plc ADR: no published value
• NCNA - NuCana plc ADR: no published value
• AKAN - Akanda Corp: not valued
• VRAX - Virax Biolabs Group Ltd: undervalued, +74% margin of safety
• BDRX - Biodexa Pharmaceuticals Plc ADR: no published value